# FDA Inspection 1307736 - Paul W. Wallace, MD - March 17, 2026

Source: https://www.globalkeysolutions.net/records/fda_inspections/paul-w-wallace-md/f6ed70f6-0bc5-4521-9c11-8fcd6786192e/
Source feed: FDA_Inspections

> FDA Inspection 1307736 for Paul W. Wallace, MD on March 17, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1307736
- Company Name: Paul W. Wallace, MD
- Inspection Date: 2026-03-17
- Project Area: Bioresearch Monitoring: Human Drugs
- Product Type: Human Drugs
- Office Name: Los Angeles District Office

## Related Documents

- [FDA Inspection 1208694 - 2023-06-16](https://www.globalkeysolutions.net/api/records/fda_inspections/paul-w-wallace-md/cc70216d-4369-48ff-9af7-c83ad66217f1/)
- [FDA Inspection 1055969 - 2018-06-08](https://www.globalkeysolutions.net/api/records/fda_inspections/paul-w-wallace-md/3527f127-26e3-41e1-9e59-f8fa618a9260/)

Company: https://www.globalkeysolutions.net/companies/paul-w-wallace-md/c6e736a3-93ff-4b83-aa9d-86fb904877ca

Office: https://www.globalkeysolutions.net/offices/los-angeles-district-office/edcf1dfe-596a-43b8-8df4-07d9cd94763b